التفاصيل البيبلوغرافية
| العنوان: |
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial |
| المؤلفون: |
Dooley, Kelly E, Rosenkranz, Susan L, Conradie, Francesca, Moran, Laura, Hafner, Richard, von Groote-Bidlingmaier, Florian, Lama, Javier R., Shenje, Justin, De Los Rios, Jorge, Comins, Kyla, Morganroth, Joel, Diacon, Andreas H, Cramer, Yoninah S, Donahue, Kathleen, Maartens, Gary, Alli, Oladapo, Gottesman, Joan, Guevara, Maria, Hikuam, Chris, Hovind, Laura, Karlsson, Mats, McClaren, Jennifer, McIlleron, Helen, Murtaugh, William, Rolls, Barbara, Shahkolahi, Akbar, Stone, Lynnett, Tegha, Gerald, Tenai, Jacob, Upton, Caryn, Wimbish, Chanelle |
| المصدر: |
The Lancet Infectious Diseases ; volume 21, issue 7, page 975-983 ; ISSN 1473-3099 |
| بيانات النشر: |
Elsevier BV |
| سنة النشر: |
2021 |
| المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1016/s1473-3099(20)30770-2 |
| الاتاحة: |
http://dx.doi.org/10.1016/s1473-3099(20)30770-2
https://api.elsevier.com/content/article/PII:S1473309920307702?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1473309920307702?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ ; https://doi.org/10.15223/policy-017 ; https://doi.org/10.15223/policy-037 ; https://doi.org/10.15223/policy-012 ; https://doi.org/10.15223/policy-029 ; https://doi.org/10.15223/policy-004 |
| رقم الانضمام: |
edsbas.1F9BE469 |
| قاعدة البيانات: |
BASE |